Arsenic trioxide and acute promyelocytic leukemia:: Clinical and biological

被引：0
|
作者：
Chen, Z.
Zhao, W-L.
Shen, Z-X.
Li, J-M.
Chen, S-J.
Zhu, J.
Lallemand-Breittenbach, V.
Zhou, J.
Guillemin, M-C.
Vitoux, D.
de The, H.
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Rui Jin Hosp, Sch Med, Shanghai 200025, Peoples R China
[2] Hop St Louis, CNRS, UMR 7151, Hop St Louis, F-75475 Paris, France
来源：
ACUTE PROMYELOCYTIC LEUKEMIA: MOLECULAR GENETICS, MOUSE MODELS AND TARGETED THERAPY | 2007年 / 313卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Arsenic has recently been identified as an effective drug in the treatment of newly diagnosed and relapsed acute promyelocytic leukemia. Indeed, arsenic trioxide combined with all-trans retinoic acid shows a synergistic effect. Mechanistically, arsenic targets the key leukemogenic protein PML-RAR alpha, setting up a new example of molecular target-based cancer therapy.
引用
收藏
页码：129 / 144
页数：16
相关论文
共 50 条
  • [41] The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients
    Ghiuzeli, Cristina M.
    Styblo, Miroslav
    Saunders, Jesse
    Calabro, Anthony
    Budman, Daniel
    Allen, Steven
    Devoe, Craig
    Dhingra, Radhika
    LEUKEMIA & LYMPHOMA, 2022, 63 (03) : 653 - 663
  • [42] Treatment of Relapsed Acute Promyelocytic Leukemia by Arsenic Trioxide in Iran
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    Jahani, Mohamad
    Mousavi, Asadolah
    Iravani, Masoud
    Rostami, Shahrbano
    Ghaffari, Hamidolah
    Hosseini, Roholah
    Jalili, Mehdi
    ARCHIVES OF IRANIAN MEDICINE, 2011, 14 (03) : 167 - 169
  • [43] Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia
    Au, WY
    Kumana, CR
    Kou, M
    Mak, R
    Chan, GCF
    Lam, CW
    Kwong, YL
    BLOOD, 2003, 102 (01) : 407 - 408
  • [44] Clinical Study of Children with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: A Multicenter Study
    Zhu, J.
    Zhai, X.
    Yang, J.
    Wang, H.
    Li, H.
    Jiang, H.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S191 - S192
  • [45] The clinical observation on arsenic trioxide with ATRA in treating acute promyelocytic leukemia for six years
    Zhong, Zhou
    Liu, Zhen-cai
    Li, Jian-wei
    BLOOD, 2007, 110 (11) : 843A - 843A
  • [46] Clinical Study of Children with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: A Multicenter Study
    Jiang, H.
    Zhu, J.
    Yang, J.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S202 - S202
  • [47] Arsenic Trioxide for the Treatment of a Relapsed Acute Promyelocytic Leukemia With Acute Renal Failure
    Yoon, Hoi Soo
    Park, Tae Sung
    Jeong, Kyung Hwan
    PEDIATRIC BLOOD & CANCER, 2011, 57 (06) : 1085 - 1085
  • [48] Toward Candidate Proteomic Biomarkers in Clinical Monitoring of Acute Promyelocytic Leukemia Treatment with Arsenic Trioxide
    Cao, Fenglin
    Li, Xingang
    Yang, Yiju
    Fang, Honghong
    Qu, Haixia
    Chang, Naibai
    Ma, Qingwei
    Cao, Weifan
    Zhou, Jin
    Wang, Wei
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2019, 23 (02) : 119 - 130
  • [49] Ascorbic acid - modulation of arsenic trioxide toxicity: implication for the clinical treatment of acute promyelocytic leukemia
    Yedjou, Clement G.
    Brown, Erika
    Rogers, Christian
    Tchounwou, Paul B.
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 10, 2008, 10 : 413 - 418
  • [50] Experience with use of IV arsenic trioxide for acute promyelocytic leukemia in Myanmar
    Gyi, Aye Aye
    Mra, Rai
    Nyein, Htun Lwin
    Win, Sein
    Htut, Khin Thida
    Han, Yin Nwet
    LEUKEMIA & LYMPHOMA, 2013, 54 : 22 - 22
12345